Vivozon Pharmaceutical Co., Ltd. (KOSDAQ: 082800)

Vivozon Pharmaceutical Revenue

Vivozon Pharmaceutical had revenue of 23.63B KRW in the quarter ending September 30, 2024, with 32.21% growth. This brings the company's revenue in the last twelve months to 87.28B, up 37.32% year-over-year. In the year 2023, Vivozon Pharmaceutical had annual revenue of 71.32B with 38.31% growth.

• Revenue (ttm): 87.28B
• Revenue Growth: +37.32%
• P/S Ratio: 4.95
• Revenue / Employee: 266.08M
• Employees: 328
• Market Cap: 449.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	71.32B	19.75B	38.31%
Dec 31, 2022	51.56B	-6.00B	-10.42%
Dec 31, 2021	57.56B	13.97B	32.04%
Dec 31, 2020	43.59B	-1.36B	-3.03%
Dec 31, 2019	44.95B	-1.05B	-2.28%